Novo Nordisk India execs urge early Wegovy launch as weight-loss rival looms

Novo Nordisk’s (NOVOb.CO) team in India has been pushing the Danish drugmaker’s global leadership for an earlier launch of its popular weight-loss drug Wegovy over fears of falling behind rival Eli Lilly (LLY.N) in the potentially huge market, two sources familiar with the plans told Reuters.